SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-006496
Filing Date
2022-02-24
Accepted
2022-02-24 07:30:00
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20220224.htm   iXBRL 8-K 43751
2 EX-99.1 cccc-ex991_7.htm EX-99.1 102988
3 GRAPHIC gxwtbapwkwil000001.jpg GRAPHIC 7489
  Complete submission text file 0001564590-22-006496.txt   297554

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cccc-20220224.xsd EX-101.SCH 5693
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cccc-20220224_lab.xml EX-101.LAB 19335
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cccc-20220224_pre.xml EX-101.PRE 11492
8 EXTRACTED XBRL INSTANCE DOCUMENT cccc-8k_20220224_htm.xml XML 3546
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 22666525
SIC: 2836 Biological Products, (No Diagnostic Substances)